These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 37979723)
1. Management of triglycerides, non-high density lipoprotein cholesterol and high density lipoprotein cholesterol. Zachariah G Indian Heart J; 2024 Mar; 76 Suppl 1(Suppl 1):S58-S64. PubMed ID: 37979723 [TBL] [Abstract][Full Text] [Related]
2. Nutrition interventions for adults with dyslipidemia: A Clinical Perspective from the National Lipid Association. Kirkpatrick CF; Sikand G; Petersen KS; Anderson CAM; Aspry KE; Bolick JP; Kris-Etherton PM; Maki KC J Clin Lipidol; 2023; 17(4):428-451. PubMed ID: 37271600 [TBL] [Abstract][Full Text] [Related]
4. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome. Nesto RW Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526 [TBL] [Abstract][Full Text] [Related]
5. Increased triglyceride/high-density lipoprotein cholesterol ratio may be associated with reduction in the low-density lipoprotein particle size: assessment of atherosclerotic cardiovascular disease risk. Yokoyama K; Tani S; Matsuo R; Matsumoto N Heart Vessels; 2019 Feb; 34(2):227-236. PubMed ID: 30140959 [TBL] [Abstract][Full Text] [Related]
7. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies. Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300 [TBL] [Abstract][Full Text] [Related]
8. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels. Querton L; Buysschaert M; Hermans MP J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779 [TBL] [Abstract][Full Text] [Related]
9. New targets for treating hypertriglyceridemia. Parhofer KG Curr Opin Endocrinol Diabetes Obes; 2022 Apr; 29(2):106-111. PubMed ID: 35045528 [TBL] [Abstract][Full Text] [Related]
10. [Diabetic dyslipidaemia and the atherosclerosis]. Márk L; Dani G Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274 [TBL] [Abstract][Full Text] [Related]
11. Residual Atherosclerotic Cardiovascular Disease Risk: Focus on Non-High-Density Lipoprotein Cholesterol. Luo Y; Peng D J Cardiovasc Pharmacol Ther; 2023; 28():10742484231189597. PubMed ID: 37641208 [TBL] [Abstract][Full Text] [Related]
12. Management of dyslipidemia in the metabolic syndrome: recommendations of the Spanish HDL-Forum. Ascaso J; Gonzalez Santos P; Hernandez Mijares A; Mangas Rojas A; Masana L; Millan J; Pallardo LF; Pedro-Botet J; Perez Jimenez F; Pintó X; Plaza I; Rubiés J; Zúñiga M Am J Cardiovasc Drugs; 2007; 7(1):39-58. PubMed ID: 17355165 [TBL] [Abstract][Full Text] [Related]
13. Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study. Ikezaki H; Lim E; Cupples LA; Liu CT; Asztalos BF; Schaefer EJ J Am Heart Assoc; 2021 Feb; 10(5):e019140. PubMed ID: 33586462 [TBL] [Abstract][Full Text] [Related]
14. Cholesterol efflux and metabolic abnormalities associated with low high-density-lipoprotein-cholesterol and high triglycerides in statin-treated coronary men with low-density lipoprotein-cholesterol <70 mg/dl. Posadas-Sánchez R; Posadas-Romero C; Mendoza-Pérez E; Caracas-Portilla NA; Cardoso-Saldaña G; Medina-Urrutia A; Jorge-Galarza E; Juárez-Rojas JG Am J Cardiol; 2012 Mar; 109(5):636-41. PubMed ID: 22169129 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease and dyslipidemia: beyond LDL. Pöss J; Custodis F; Werner C; Weingärtner O; Böhm M; Laufs U Curr Pharm Des; 2011; 17(9):861-70. PubMed ID: 21418031 [TBL] [Abstract][Full Text] [Related]
16. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update. Reiner Z Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901 [TBL] [Abstract][Full Text] [Related]
17. A More Atherogenic Lipoprotein Status Is Present in Adults With Type 2 Diabetes Mellitus Than in Those Without With Equivalent Degrees of Hypertriglyceridemia. Sun CJ; Brisson D; Sharma R; Birkett N; Gaudet D; Ooi TC Can J Diabetes; 2022 Jul; 46(5):480-486. PubMed ID: 35718690 [TBL] [Abstract][Full Text] [Related]